{"transactions":[{"id":4634643,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25863,"kind":"person","name":"Elrifi Ivor","position":1,"cik":"0002136241","reported_name":"Elrifi Ivor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-29T21:13:13.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":false,"shares":1050000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were granted on August 15, 2024 vesting in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were granted on August 15, 2024 vesting in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028."}],"balance_after":2100000,"derivative":{"underlying":"COMMON STOCK","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0001213900-26-104755","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723069/000121390026104755/ownership.xml","form_type":"4"}},{"id":4634642,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25863,"kind":"person","name":"Elrifi Ivor","position":1,"cik":"0002136241","reported_name":"Elrifi Ivor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"COMMON STOCK","published_at":"2026-09-29T21:13:13.000Z","date":"2026-08-15","kind":"exercise","planned":false,"acquired":true,"shares":1050000,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":5843684,"source":{"system":"sec-edgar","filing":"0001213900-26-104755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723069/000121390026104755/ownership.xml","form_type":"4"}},{"id":693372,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:16:31.000Z","date":"2026-07-21","kind":"purchase","planned":false,"acquired":true,"shares":42357,"price":0.99,"value":41933.43,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":44814587,"source":{"system":"sec-edgar","filing":"0001213900-26-086697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000121390026086697/ownership.xml","form_type":"4/A","original_submission_date":"2026-07-23"}},{"id":693369,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-08-07T20:15:31.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.11,"value":16650.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":44772230,"source":{"system":"sec-edgar","filing":"0001213900-26-086696","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000121390026086696/ownership.xml","form_type":"4/A","original_submission_date":"2026-06-17"}},{"id":694171,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25863,"kind":"person","name":"Elrifi Ivor","position":1,"cik":"0002136241","reported_name":"Elrifi Ivor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"COMMON STOCK","published_at":"2026-08-06T13:30:02.000Z","date":"2026-08-05","kind":"purchase","planned":false,"acquired":true,"shares":237616,"price":1,"value":237616.0,"ownership":{"direct":false,"nature":"By trust"},"balance_after":4793684,"source":{"system":"sec-edgar","filing":"0001213900-26-085950","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723069/000121390026085950/ownership.xml","form_type":"4"}},{"id":694170,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25863,"kind":"person","name":"Elrifi Ivor","position":1,"cik":"0002136241","reported_name":"Elrifi Ivor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"COMMON STOCK","published_at":"2026-08-06T13:30:02.000Z","date":"2026-08-04","kind":"purchase","planned":false,"acquired":true,"shares":83807,"price":0.97,"value":81292.79,"ownership":{"direct":false,"nature":"By trust"},"balance_after":4556068,"source":{"system":"sec-edgar","filing":"0001213900-26-085950","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723069/000121390026085950/ownership.xml","form_type":"4"}},{"id":695763,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25863,"kind":"person","name":"Elrifi Ivor","position":1,"cik":"0002136241","reported_name":"Elrifi Ivor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"COMMON STOCK","published_at":"2026-08-05T20:30:21.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":667000,"price":1,"value":667000.0,"ownership":{"direct":false,"nature":"By trust"},"balance_after":4472261,"source":{"system":"sec-edgar","filing":"0001213900-26-085710","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723069/000121390026085710/ownership.xml","form_type":"4"}},{"id":704174,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-07-23T20:15:30.000Z","date":"2026-07-21","kind":"grant","planned":false,"acquired":true,"shares":42357,"price":0.99,"value":41933.43,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":44814587,"source":{"system":"sec-edgar","filing":"0001213900-26-080880","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000121390026080880/ownership.xml","form_type":"4"}},{"id":734692,"issuer":{"id":6639,"kind":"organization","name":"Tiziana Life Sciences Ltd"},"owners":[{"id":25537,"kind":"person","name":"CERRONE GABRIELE M","position":1,"cik":"0001139306","reported_name":"CERRONE GABRIELE M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2026-06-17T10:31:44.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":1.11,"value":16650.0,"ownership":{"direct":false,"nature":"Via Panetta Partners Limited"},"balance_after":44772230,"source":{"system":"sec-edgar","filing":"0001213900-26-069424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1139306/000121390026069424/ownership.xml","form_type":"4"}}]}